Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acrux Limited (AU:ACR)
ASX:ACR
Holding AU:ACR?
Track your performance easily
ACR Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.03 - AU$0.10
Previous CloseAU$0.03
Volume128.55K
Average Volume (3M)568.29K
Market Cap
AU$12.38M
Enterprise ValueAU$8.62M
Total Cash (Recent Filing)AU$5.83M
Total Debt (Recent Filing)AU$2.08M
Price to Earnings (P/E)―
Beta-0.49
Next Earnings
Feb 20, 2025EPS EstimateN/A
Last Dividend Ex-Date
Aug 18, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. Volume2,332,682
30 Day Avg. Volume568,286
Standard Deviation0.18
R-Squared0.13
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)9.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Acrux Limited News
PremiumCompany Announcements
Acrux Limited Attracts Increased Investment from Phillip Asset Management
PremiumCompany Announcements
Acrux Limited Lists New Shares on ASX
PremiumCompany Announcements
Acrux Launches Nitroglycerin Ointment and Offers Share Purchase Plan
PremiumCompany Announcements
Acrux Limited Updates Investors on Product Commercialisation
PremiumCompany Announcements
Acrux Limited Expands U.S. Market with New Ointment
PremiumCompany Announcements
Acrux Limited Strengthens Financial Position with Share Placement
PremiumCompany Announcements
Acrux Limited Announces Director’s Shareholding ChangesPremiumCompany Announcements
Acrux Limited Updates on Director’s Interest ChangesOptions Prices
Currently, No data available
---
Ownership Overview
ACR FAQ
What was Acrux Limited’s price range in the past 12 months?
Acrux Limited lowest share price was AU$0.03 and its highest was AU$0.10 in the past 12 months.
What is Acrux Limited’s market cap?
Currently, no data Available
When is Acrux Limited’s upcoming earnings report date?
Acrux Limited’s upcoming earnings report date is Feb 20, 2025 which is in 59 days.
How were Acrux Limited’s earnings last quarter?
Acrux Limited released its earnings results on Aug 28, 2024. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.
Is Acrux Limited overvalued?
According to Wall Street analysts Acrux Limited’s price is currently Overvalued.
Does Acrux Limited pay dividends?
Acrux Limited pays a Notavailable dividend of AU$0.059 which represents an annual dividend yield of N/A. See more information on Acrux Limited dividends here
What is Acrux Limited’s EPS estimate?
Acrux Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acrux Limited have?
Acrux Limited has 364,005,550 shares outstanding.
What happened to Acrux Limited’s price movement after its last earnings report?
Acrux Limited reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of Acrux Limited?
Currently, no hedge funds are holding shares in AU:ACR
---
Acrux Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ACR Sentiment 71%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.85%
12-Months-Change
Fundamentals
Return on Equity
-95.25%
Trailing 12-Months
Asset Growth
-30.16%
Trailing 12-Months
Company Description
Acrux Limited
Acrux Ltd is an Australian pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. It has developed and commercialized, through licensees, several pharmaceutical products in the US, Europe, and other markets. Its products include Testosterone Solution, Estradiol MDTS. It also has some of its products under pipeline.
---
Technical Analysis
---